Herold Lab

Focus of Research 

The research at Herold Lab is dedicated to unraveling the mechanisms driving anti-viral host defense, to dissecting the cellular and molecular contributors to the tissue damage at the virus-host interface in the distal lung, and to defining pathways and mediators of organ regeneration in the context of viral infection. We focus on the interaction of macrophages with parenchymal cells of the distal lung and the epithelial stem cell niche.

Moreover, we study mechanisms that lead to increased susceptibility to bacterial infections during viral pneumonia or acid aspiration with a focus on alveolar macrophages. These aims will be achieved by using established models of in vivo virus infection, acid aspiration and bacterial superinfection of different levels of complexity (in vitro – ex vivo – in vivo) combined with analyses of patient samples.

We utilize tools such as FACS and cell sorting (LSR Fortezza, FACSAriaIII), NGS including single cell RNA-Seq, organoid modeling, and high-resolution microscopy/life imaging techniques. The ultimate goal is to find novel disease biomarkers defining susceptibility to and recovery from ALI, and to identify distinct host targets to be harnessed for novel therapeutic strategies to combat severe respiratory viral infection, and bacterial superinfections due to viral or non-infectious insults in the lung.

Susanne Herold
Prof. Dr. med. Susanne Herold, PhD

LOEWE Professorship of Excellence Awarded to Prof. Dr. Susanne Herold!

The medical doctor and infectious diseases specialist receives a LOEWE Professorship of Excellence at Justus Liebig University Giessen with three million euros in research funding from the state of Hessen.

Lab Members

PostDocs

Irina Kuznetsova

Irina Kuznetsova, PhD

Project description: In severe cases SARS-CoV2 disease-2019 (COVID-19), virus-induced pneumonia leads to development of disseminated intravascular coagulation, endothelial leakage, acute respiratory distress syndrome (ARDS) and multi-organ failure. The main goal of my project is to elucidate the molecular cross-talk between alveolar epithelial cells, tissue-resident alveolar macrophages and pulmonary microvascular endothelial cells in order to develop an approach for treatment of SARS-CoV2-induced lung injury.

Learta Pervizaj

Dr. biol. Hom. Learta Pervizaj-Oruqaj

Project description: This project is dedicated to elucidate the intricate mechanisms governing lung damage and recovery during severe Influenza A virus (IAV) infections, with a primary focus on alveolar macrophages and their expression of Placenta-expressed transcript 1 (Plet1). The project’s objectives encompass the advancement of our comprehension of the macrophage-epithelial cell crosstalk, ultimately preserving lung function and mitigating severe viral pneumonia consequences. Additionally, we are committed to delve into Plet1’s mode of action and signal transduction pathways it engages, to provide profound insights into lung repair, paving the way for innovative approaches to address respiratory infections and improve patient outcomes.

Margarida Barroso

Margarida Barroso, PhD

Project description: Mesenchymal stem cells (MSC) show promising therapeutic potential in different forms of acute lung injury. However, it is not clear how MSC sense injury during viral lung infections. The aim of this project is to understand how the anti-viral and tissue-protective effects of bone marrow derived-MSC (BM-MSC) are mediated and can be applied in the context of influenza-virus (IV) infection.

Christina Malaino

Dr. med. Christina Malainou

Project description: Influenza virus-induced pneumonia initiates a variety of immune responses within the alveoli, which eventually compromise host defense, causing the depletion of the local, tissue-resident alveolar macrophage (TR-AM) pool, which paves the way for the establishment of secondary bacterial infections, with a potentially lethal outcome. In this project, we aim to elucidate the pathomechanisms behind influenza-associated TR-AM loss to attenuate disease progress and prevent the transition to post-influenza bacterial pneumonia.

Maximiliano Ferrero

Maximiliano Ferrero, PhD (Guest Scientist)

Project description: The immune response to severe respiratory infections can contribute to lung damage, but it is also crucial to promote repair once the infection is resolved. By unraveling the immune-epithelial cell cross talk, we study how alveolar macrophages mediate epithelial regeneration to preserve the lung during severe viral pneumonia.

PhD Students

Theresa Schäfer

Theresa Schäfer

Project description: The granulocyte-macrophage colony-stimulating factor (GM-CSF) is known to have a beneficial effect on epithelial repair in acute lung injury. We investigate how GM-CSF facilitates alveolar epithelial repair in severe influenza virus pneumonia and examine the underlying GM-CSF-mediated molecular mechanisms.

Afaq Mushtaq

Afaq Mushtaq

Project description: Coming soon

MD students

Dorgeline Blanche Nganko

Dorgeline Blanche Nganko

Martin Langelage

Martin Langelage

Michael-Wettstein

Michael Wettstein

Maximilian Löwe

Maximilian Löwe

Technical staff

Larissa Hamann

Larissa Hamann

Stefanie Jarmer

Stefanie Jarmer

Florian Lück

Florian Lück

Julia Stark

Julia Stark

Josefine Guth

Laboratory Veterinarian

Sandra Rinnert

Sandra Rinnert

Study Nurse

Nicole Tewes

Nicole Tewes

Alumni

Jun-Prof. Dr. Ana Ivonne Vazquez-Armendariz

Jun-Prof. Dr. Ana Ivonne Vazquez-Armendariz

Anna-Lena Ament, M.Sc.

Anna-Lena Ament, M.Sc.

Christin Peteranderl, PhD

Christin Peteranderl, PhD

Dr. rer. Nat. Lucie Sauerhering

Dr. rer. Nat. Lucie Sauerhering

Jennifer Quantius, PhD

Jennifer Quantius, PhD

Dr. Carole Schmoldt

Dr. Carole Schmoldt

Dr. Julia Bespalowa

Dr. Julia Bespalowa

Balachandar Selvakumar, PhD

Balachandar Selvakumar, PhD

Lina Jankauskaite, MD PhD

Lina Jankauskaite, MD PhD

Featured Publications

  • Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018

    5. Dezember 2022

    Rohde AM, Walker S, Behnke M, Eisenbeis S, Falgenhauer L, Falgenhauer JC, Häcker G, Hölzl F, Imirzalioglu C, Käding N, Kern WV, Kola A, Kramme E, Mischnik A, Peter S, Rieg S, Rupp J, Schneider C, Schwab F, Seifert H, Tacconelli E, Tobys D, Trauth J, Weber A, Xanthopoulou K, […]

  • The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics

    29. Juli 2022

    Schons M, Pilgram L, Reese JP, Stecher M, Anton G, Appel KS, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, Brechtel M, Brinkmann F, Brünn C, Dhillon C, Fiessler C, Geisler R, Hamelmann E, Hansch S, Hanses F, Hanß S, Herold S, Heyder R, Hofmann AL, Hopff SM, Horn A, […]

  • Hodgkin Lymphoma after Disseminated Mycobacterium genavense Infection, Germany

    28. Juli 2022

    Trauth J, Discher T, Fritzenwanker M, Imirzalioglu C, Arnold T, Steiner D, Richter E, Crisponi L, Grimbacher B, Herold S. Hodgkin Lymphoma after Disseminated Mycobacterium genavense Infection, Germany. Emerg Infect Dis. 2022 Jul;28(7):1506-1509. doi: 10.3201/eid2807.220425. PMID: 35731199; PMCID: PMC9239878.

    Mycobacterium genavense infection, a rare nontuberculous […]

Funding & Cooperation Partners

Herold Lab is always open for collaborations with partners from academia, industry, and the public sector. We are interested in translating our research findings into practice and jointly developing innovative solutions. Funding is a crucial part of our work, enabling us to conduct our research at the highest level. Therefore, we appreciate any contribution that supports us in achieving our goals. Please feel free to contact us for more information.